Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Genpact Raises FY2025 GAAP EPS Guidance from $2.90-$3.01 to $2.98-$3.05 vs $3.00 Est

Author: Benzinga Newsdesk | August 07, 2025 04:30pm
Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS8

(Per share data)



 


 


 
Year ending December 31, 2025


 


 
Lower

 
Upper
Diluted EPS

 
$               2.98

 
$                3.05
Estimated stock-based compensation expense

 
0.52

 
0.52
Estimated amortization of acquired intangible assets

 
0.14

 
0.14
Estimated acquisition expense

 
0.01

 
0.01
Estimated tax impact on stock-based compensation expense

 
(0.09)

 
(0.09)
Estimated tax impact on amortization of acquired intangible assets

 
(0.04)

 
(0.04)
Adjusted diluted EPS

 
$                3.51

 
$                3.58

Posted In: G

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist